Medi Caps' Stock Price Surges, Outperforming Market and Showing Potential for Growth
Medi Caps, a microcap pharmaceutical company, has seen a surge in its stock price, reaching a 52-week high of Rs.63.49 on January 30, 2024. Despite a 'Sell' rating from MarketsMojo, the company's performance is in line with the sector and has shown consecutive gains, outperforming the market. With a strong performance over the past year and positive market indicators, Medi Caps has the potential for growth and is a company to watch out for.
Medi Caps, a microcap pharmaceutical company, has recently seen a surge in its stock price, reaching a 52-week high of Rs.63.49 on January 30, 2024. This increase in price has caught the attention of investors and market analysts.
According to MarketsMOJO, a leading stock market analysis platform, the current stock call for Medi Caps is 'Sell'. However, the company's performance today is in line with the overall sector, indicating a stable market trend.
In the past two days, Medi Caps has shown consecutive gains and has risen by 9.47%, outperforming the market. The stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.
In comparison to the Sensex, Medi Caps has shown a strong performance over the past year, with a 37.44% increase in stock price, while the Sensex has only seen a 20.71% increase. This showcases the company's potential for growth and its ability to outperform the market.
As a microcap company, Medi Caps may not be as well-known as its larger counterparts in the pharmaceutical industry. However, its recent stock performance and positive market indicators make it a company to watch out for in the future.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
